Mechanisms of molecular mimicry involving the microbiota in neurodegeneration

RP Friedland - Journal of Alzheimer's Disease, 2015 - content.iospress.com
The concept of molecular mimicry was established to explain commonalities of structure
which developed in response to evolutionary pressures. Most examples of molecular …

[HTML][HTML] Animal models of Alzheimer's disease: Applications, evaluation, and perspectives

ZY Chen, Y Zhang - Zoological Research, 2022 - ncbi.nlm.nih.gov
Although great advances in elucidating the molecular basis and pathogenesis of
Alzheimer's disease (AD) have been made and multifarious novel therapeutic approaches …

A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity

BS Johnson, JM McCaffery… - Proceedings of the …, 2008 - National Acad Sciences
Protein misfolding is intimately associated with devastating human neurodegenerative
diseases, including Alzheimer's, Huntington's, and Parkinson's. Although disparate in their …

Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?

V Khurana, S Lindquist - Nature Reviews Neuroscience, 2010 - nature.com
In ageing populations, neurodegenerative diseases increase in prevalence, exacting an
enormous toll on individuals and their communities. Multiple complementary experimental …

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases

ST Ferreira, MNN Vieira, FG De Felice - IUBMB life, 2007 - Wiley Online Library
Amyloid diseases are a group of degenerative disorders characterized by cell/tissue
damage caused by toxic protein aggregates. Abnormal production, processing and/or …

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity

J Ring, J Tadic, S Ristic, M Poglitsch… - EMBO Molecular …, 2022 - embopress.org
Abstract Amyloid beta 42 (Abeta42) is the principal trigger of neurodegeneration during
Alzheimer's disease (AD). However, the etiology of its noxious cellular effects remains …

Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies

Y Jiang, LT MacNeil - Molecular Neurodegeneration, 2023 - Springer
The lack of effective therapies that slow the progression of Alzheimer's disease (AD) and
related tauopathies highlights the need for a more comprehensive understanding of the …

Overview of beneficial effects of (poly) phenol metabolites in the context of neurodegenerative diseases on model organisms

D Carregosa, S Mota, S Ferreira, B Alves-Dias… - Nutrients, 2021 - mdpi.com
The rise of neurodegenerative diseases in an aging population is an increasing problem of
health, social and economic consequences. Epidemiological and intervention studies have …

Harnessing the power of yeast to unravel the molecular basis of neurodegeneration

S Tenreiro, MC Munder, S Alberti… - Journal of …, 2013 - Wiley Online Library
Several neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's
disease (AD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), or prion …

Yeast as a model for studying human neurodegenerative disorders

L Miller‐Fleming, F Giorgini… - Biotechnology Journal …, 2008 - Wiley Online Library
Protein misfolding and aggregation are central events in many disorders including several
neurodegenerative diseases. This suggests that alterations in normal protein homeostasis …